We are live on ! Find out more
NVPX

Norwest Venture Partners XII Portfolio holdings

AUM $75.4M
1-Year Est. Return 53.35%
This Fund
S&P 500
This Quarter Est. Return
+31.29%
1 Year Est. Return
-53.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$86M
AUM Growth
+$16.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.76%
2 Consumer Discretionary 20.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCAT icon
1
Health Catalyst
HCAT
$131M
$68.6M 79.76%
2,352,090
CSPR
2
DELISTED
Casper Sleep Inc.
CSPR
$17.4M 20.24%
1,940,576

Similar funds

Norwest Venture Partners XII's Q2 2020 Portfolio in Review

As of Q2 2020, Norwest Venture Partners XII held 2 positions worth $86M, up 23% from $69.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 0%. Norwest Venture Partners XII opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 88% a quarter earlier, followed by Consumer Discretionary.

  • Norwest Venture Partners XII's ten largest holdings make up 100% of its $86M portfolio in Q2 2020.
  • Norwest Venture Partners XII opened 0 new positions and closed 0 in Q2 2020.
  • Norwest Venture Partners XII's portfolio value rose 23% quarter-over-quarter to $86M.

Based on Norwest Venture Partners XII's 13F filing for Q2 2020, filed 14 Jul 2020.